Ponticelli C , Glassock RJ . Glomerular diseases: membranous nephropathy—a modern view. Clin J Am Soc Nephrol 2014; 9:609–616.

• PubMed
Ponticelli C , Glassock RJ . Glomerular diseases: membranous nephropathy—a modern view. Clin J Am Soc Nephrol 2014; 9:609–616.)| false
• Search Google Scholar
• Export Citation

Radhakrishnan J , Cattran DC . The KDIGO clinical practice guideline on glomerulonephritis: reading (guide)lines—application to the individual patient. Kidney Int 2012; 82(2):840–856.

• PubMed
Radhakrishnan J , Cattran DC . The KDIGO clinical practice guideline on glomerulonephritis: reading (guide)lines—application to the individual patient. Kidney Int 2012; 82(2):840–856.)| false
• Search Google Scholar
• Export Citation

Beck LH Jr , et al.. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 2009; 361:11–21.

• PubMed
Beck LH Jr , . M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 2009; 361:11–21.)| false
• Search Google Scholar
• Export Citation

Dussol B , et al.. Mycophenolate mofetil monotherapy in membranous nephropathy: a 1-year randomized controlled trial. Am J Kidney Dis 2008; 52:699–705.

• PubMed
Dussol B , . Mycophenolate mofetil monotherapy in membranous nephropathy: a 1-year randomized controlled trial. Am J Kidney Dis 2008; 52:699–705.)| false
• Search Google Scholar
• Export Citation

Branten AJ , et al.. Mycophenolate mofetil in idiopathic membranous nephropathy: a clinical trial with comparison to a historic control group treated with cyclophosphamide. Am J Kidney Dis 2007; 50:248–256.

• PubMed
Branten AJ , . Mycophenolate mofetil in idiopathic membranous nephropathy: a clinical trial with comparison to a historic control group treated with cyclophosphamide. Am J Kidney Dis 2007; 50:248–256.)| false
• Search Google Scholar
• Export Citation

Chan TM , et al.. Prospective controlled study on mycophenolate mofetil and prednisolone in the treatment of membranous nephropathy with nephrotic syndrome. Nephrology (Carlton) 2007; 12:576–581.

• PubMed
Chan TM , . Prospective controlled study on mycophenolate mofetil and prednisolone in the treatment of membranous nephropathy with nephrotic syndrome. Nephrology (Carlton) 2007; 12:576–581.)| false
• Search Google Scholar
• Export Citation

Senthil Nayagam L , et al.. Mycophenolate mofetil or standard therapy for membranous nephropathy and focal segmental glomerulosclerosis: a pilot study. Nephrol Dial Transplant 2008; 23:1926–1930.

• PubMed
Senthil Nayagam L , . Mycophenolate mofetil or standard therapy for membranous nephropathy and focal segmental glomerulosclerosis: a pilot study. Nephrol Dial Transplant 2008; 23:1926–1930.)| false
• Search Google Scholar
• Export Citation

Berg AL , et al.. Beneficial effects of ACTH on the serum lipoprotein profile and glomerular function in patients with membranous nephropathy. Kidney Int 1999; 56:1534–1543.

• PubMed
Berg AL , . Beneficial effects of ACTH on the serum lipoprotein profile and glomerular function in patients with membranous nephropathy. Kidney Int 1999; 56:1534–1543.)| false
• Search Google Scholar
• Export Citation

Ponticelli C , et al.. A randomized pilot trial comparing methylprednisolone plus a cytotoxic agent versus synthetic adrenocorticotropic hormone in idiopathic membranous nephropathy. Am J Kidney Dis 2006; 47:233–240.

• PubMed
Ponticelli C , . A randomized pilot trial comparing methylprednisolone plus a cytotoxic agent versus synthetic adrenocorticotropic hormone in idiopathic membranous nephropathy. Am J Kidney Dis 2006; 47:233–240.)| false
• Search Google Scholar
• Export Citation

Bomback AS , et al.. Treatment of nephrotic syndrome with adrenocorticotropic hormone (ACTH) gel. Drug Des Devel Ther 2011; 5:147–153.

• PubMed
Bomback AS , . Treatment of nephrotic syndrome with adrenocorticotropic hormone (ACTH) gel. Drug Des Devel Ther 2011; 5:147–153.)| false
• Search Google Scholar
• Export Citation

Lindskog Jonsson A , et al.. Effects of melanocortin 1 receptor agonists in experimental nephropathies. PLoS One 2014; 9:e87816.

• PubMed
Lindskog Jonsson A , . Effects of melanocortin 1 receptor agonists in experimental nephropathies. PLoS One 2014; 9:e87816.)| false
• Search Google Scholar
• Export Citation

Ruggenenti P , et al.. Rituximab in idiopathic membranous nephropathy. J Am Soc Nephrol 2012; 23:1416–1425.

• PubMed
Ruggenenti P , . Rituximab in idiopathic membranous nephropathy. J Am Soc Nephrol 2012; 23:1416–1425.)| false
• Search Google Scholar
• Export Citation

Fervenza FC , et al.. Rituximab therapy in idiopathic membranous nephropathy: a 2-year study. Clin J Am Soc Nephrol 2010; 5:2188–2198.

• PubMed
Fervenza FC , . Rituximab therapy in idiopathic membranous nephropathy: a 2-year study. Clin J Am Soc Nephrol 2010; 5:2188–2198.)| false
• Search Google Scholar
• Export Citation